Epizyme: Tackling Genetically Defined Cancers One Step At A Time
Tuesday, May 27, 2014 11:23 PM EDT
Epizyme Inc., which creates therapeutics for patients with genetically defined cancers, is making a breakthrough with its technology. Biotech investors should keep a keen eye on this company.